RecruitingNot ApplicableNCT07084701

Effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on Memory and Cognitive Function in Adults With Sleep Deprivation: A Proof-of-Concept Study


Sponsor

Tao Liu

Enrollment

30 participants

Start Date

Sep 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This Effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on Memory and Cognitive Function in Adults with Sleep deprivation: A Proof-of-Concept Study aims to investigate the effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on memory and cognitive function in adults experiencing sleep deprivation(SD). Given the known impact of SD on cognitive performance, this study seeks to explore whether NSCLD, as a non-invasive intervention, can mitigate the cognitive impairments associated with SD.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • College student ≥18 years, all of whom have passed a standardized entrance examination;
  • No failed exams during the course of study;
  • Sleep deprivation;
  • In good health, with no mental or psychological disorders;
  • No recent use of medications that may affect memory and cognition;
  • Voluntary participation and able to undergo cognitive function and memory testing;
  • Informed consent provided

Exclusion Criteria5

  • Pregnant or breastfeeding women.
  • Presence of acute or chronic medical conditions (e.g., severe hypertension, diabetes, cardiovascular disease) that could confound the results.
  • History of craniocervical trauma or surgery.
  • Current use of sedative or anxiolytic medications that could influence sleep or cognitive function.
  • Participants who are unable to follow the procedures or complete the assessments

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENon-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD)

Participants will be randomly assigned to either an intervention group receiving NSCLD or a control group receiving a sham-intervention treatment. Cognitive function will be assessed using standardized tests before and after the intervention.

DEVICEsham-intervention treatment

Participants will be randomly assigned to either an intervention group receiving NSCLD or a control group receiving a sham-intervention treatment. Cognitive function will be assessed using standardized tests before and after the intervention.


Locations(1)

Tianjin Medical University General Hospital

Tianjin, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07084701


Related Trials